IQVIA(US:IQV) ZACKS·2026-02-05 18:15Core Insights - IQVIA Holdings Analytics Inc. reported strong fourth-quarter 2025 results, with adjusted earnings of $3.42 per share, exceeding the Zacks Consensus Estimate and reflecting a 9.6% year-over-year increase [2][10] - Total revenues reached $4.4 billion, surpassing the consensus estimate by 2.8% and showing a 10.3% increase from the previous year [2][10] Financial Performance - The Research and Development segment generated revenues of $2.3 billion, a 9.9% increase year-over-year, meeting the Zacks Consensus Estimate [4] - The Technology and Analytics segment reported revenues of $1.8 billion, up 9.8% year-over-year, also aligning with the consensus estimate [4] - Contract Sales and Medical Solutions revenues rose 18.6% year-over-year to $210 million, exceeding the consensus mark of $193.2 million [5] Profitability and Cash Flow - Adjusted EBITDA for Q4 2025 was $1 billion, reflecting a 5% increase from the previous year [6] - The company ended the quarter with cash and cash equivalents of $2 billion, up from $1.8 billion in the prior quarter, while long-term debt decreased to $13.9 billion from $15 billion [6] - Net cash generated from operating activities was $735 million, with capital expenditure at $174 million, resulting in $561 million in free cash flow for the quarter [7] 2026 Outlook - For 2026, IQVIA projects revenues between $17.15 billion and $17.35 billion, higher than the Zacks Consensus Estimate of $17.03 billion [8] - The expected EPS range is $12.55 to $12.85, which is below the consensus estimate of $12.93 [8] - The adjusted EBITDA outlook is set at $3.98 billion to $4.03 billion [8]